Robin Lorenz, M.D., Ph.D. and Anthony Nicholas, M.D., Ph.D., were honored with the UAB President’s Award for Excellence in Teaching.
The UAB studies are designed to test the safety and tolerability of CBD oil in patients with intractable seizures. CBD oil, a derivative of the cannabis plant, is delivered orally as an oily liquid.
A new study says that the cost of a medication may play a very important role in a patient’s perception of whether it works.
UAB has launched one of the first clinics in the nation designed to provide healthy adults with an assessment of their risk for Alzheimer’s disease.
A ramped-up immune response may play a major role in autism disorders, according to a new study from UAB and Johns Hopkins.
A new UAB study reports on a potential new treatment for frontotemporal dementia, the second most common type after Alzheimer’s disease.
Research into rare diseases gets a funding boost from the NIH: UAB researchers studying Rett syndrome and tuberous sclerosis among those involved in the national effort.
Philanthropic support has enabled the UAB Department of Neurology to make huge strides in knowledge of diseases such as Parkinson’s.
The first patient in the Southeast to get the RNS responsive neurostimulation seizure-control device implanted in the brain reports dramatic results at UAB.
The eye is a window to the brain; scientists discover early signs of dementia in changes to neurons in the eye’s retina.